Dana-Farber Cancer Institute /ID# 133494

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Non-small Cell Lung Cancer Stage III

Studies at this site

• A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC) — Stopped early